| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.4 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.4 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.4 |